Adverse Drug Reactions in Polypharmacy Among Elderly Patients: A Clinical Pharmacology Perspective
Downloads
Elderly patients are particularly vulnerable to adverse drug reactions (ADRs) due to age-related physiological changes and the common practice of polypharmacy in managing multiple chronic conditions. This study aims to identify the prevalence, risk factors, and clinical patterns of ADRs among elderly patients exposed to polypharmacy, as well as evaluate the clinical pharmacology principles behind safer prescribing practices. A prospective observational study involving 300 hospitalized elderly patients aged 65 years and older was conducted. Results showed that 39% of patients experienced at least one ADR, with central nervous system agents and cardiovascular drugs being the most implicated. Polypharmacy (≥5 medications), renal impairment, and history of prior ADRs were significant predictors. Rational pharmacological approaches, including medication review, deprescribing, and individualized dosing based on renal and hepatic function, are essential in minimizing ADRs in this population.
1. Mangoni AA, Jackson SHD. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol. 2004;57(1):6–14.
2. Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf. 2014;13(1):57–65.
3. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239–245.
4. O’Mahony D, O’Sullivan D, Byrne S, et al. STOPP/START criteria for potentially inappropriate prescribing in older people. Age Ageing. 2015;44(2):213–218.
5. Budnitz DS, Lovegrove MC, Shehab N, Richards CL. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med. 2011;365(21):2002–2012.
6. Corsonello A, Pedone C, Corica F, et al. Concealed renal insufficiency and adverse drug reactions in elderly hospitalized patients. Arch Intern Med. 2005;165(7):790–795.
7. Spinewine A, Schmader KE, Barber N, et al. Appropriate prescribing in elderly people: how well can it be measured and optimized? Lancet. 2007;370(9582):173–184.
8. Steinman MA, Hanlon JT. Managing medications in clinically complex elders: "There's got to be a happy medium". JAMA. 2010;304(14):1592–1601.
